Benzinga -
- Ontrak Inc (NASDAQ: OTRK) announced initial assessment results showing that after six months, 30% of assessed Ontrak Wholehealth+ members sustained a clinically significant reduction in anxiety symptoms, and 55% sustained a clinically significant reduction of depressive symptoms.
- Ontrak Health is one of the only behavioral services companies to institute formal PHQ-9 (a measure of depression severity) and GAD-7 (a measure of anxiety severity) assessments to gain valuable insights into their members' mental health care progress and support them.
- In June 2022, Ontrak Health implemented PHQ-9 and GAD-7 assessments as foundational measurements of its care coaching model and evidence-based Wholehealth+ program.
- While primarily used by providers, Ontrak Health has incorporated them into its care coaching model to promote better monitoring, collaboration, and accountability with its providers and customers.
- Thousands of assessments have been completed representing results for more than 1,000 unique program enrollees.
- By tracking changes in assessment scores over time, healthcare professionals can gauge the effectiveness of treatment interventions, identify issues, and take early action to address them.
- Trending on assessment scores can help patients see progress over time. It is beneficial for patients who may have a history of chronic symptoms or are experiencing new mental health concerns. The data can provide a source of information in optimizing treatment.
- Price Action: OTRK shares are up 111.3% at $1.2150 on the last check Wednesday.